Silver Lake Hospital to pay $19M over Medicare false claims
By 
Kyle Brasseur2024-01-17T17:37:00
New Jersey-based Silver Lake Hospital agreed to pay more than $18.6 million as part of a settlement with the Department of Justice (DOJ) addressing allegations of false claims submitted to Medicare for inpatient cost outlier payments.
The settlement, announced Tuesday by the DOJ, also resolves allegations Silver Lake violated the Federal Debt Collection Procedures Act (FDCPA) regarding the transfer of millions of dollars in the hospital’s money to investors without receiving equivalent value in return. As a result, Silver Lake’s principal investor and a Florida-based fund manager that serves the hospital’s investors agreed to pay $12 million in restitution.
The entire Silver Lake settlement amount is also restitution, according to the settlement agreement.
Related articles
-
News BriefDrug company and CEO pay $47 million over alleged kickbacks and false claims
A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
-
News BriefDOJ orders Baptist Health to pay $1.5M over discount policy false claims
Florida-based Baptist Health System agreed to pay $1.5 million to settle self-disclosed violations of the False Claims Act for allegedly offering discounts to patients to induce purchases or refer services reimbursed by Medicare.
-
News BriefDOJ lawsuit charges Regeneron with inflating Medicare costs
New York-based Regeneron Pharmaceuticals is being sued by the Department of Justice for allegedly flouting Medicare’s price reporting requirements.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”